Equities

Alliance Pharma PLC

Alliance Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)46.60
  • Today's Change-0.85 / -1.79%
  • Shares traded1.24m
  • 1 Year change+35.07%
  • Beta0.8153
Data delayed at least 20 minutes, as of Nov 12 2024 10:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments223229
Total Receivables, Net524828
Total Inventory262421
Prepaid expenses3.031.093.10
Other current assets, total1.230.160.06
Total current assets10410581
Property, plant & equipment, net5.725.584.83
Goodwill, net141531
Intangibles, net285379383
Long term investments------
Note receivable - long term------
Other long term assets0.480.610.37
Total assets415509503
LIABILITIES
Accounts payable18198.34
Accrued expenses171620
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.770.610.46
Other current liabilities, total4.211211
Total current liabilities414741
Total long term debt117137118
Total debt117138119
Deferred income tax385962
Minority interest------
Other liabilities, total1.970.200.21
Total liabilities197244221
SHAREHOLDERS EQUITY
Common stock5.405.405.38
Additional paid-in capital152152151
Retained earnings (accumulated deficit)5496126
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total6.5913(0.37)
Total equity218266282
Total liabilities & shareholders' equity415509503
Total common shares outstanding540540538
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.